Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
10/2001
10/10/2001EP1140786A1 Reductive alkylation of secondary amines with hydrosilane
10/10/2001CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001EP0830350B1 n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo[b][1,5]diazepin-3-yl)-acetamides
10/04/2001CA2403787A1 Il-8 receptor antagonists
10/03/2001CN1315953A Process for preparation of imidazodiazepine intermediates
09/2001
09/20/2001US20010023305 By direct reaction of an amine with an alpha, gamma-dihaloalkane or an alpha, gamma-dihaloalkene; tertiary aminoalkylorganometallics can be made by then reacting the tert haloalkylamines with an alkali metals
09/19/2001EP1134220A1 Benzoxazole derivatives and drugs containing the same as the active ingredient
09/19/2001EP0538297B1 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones
09/19/2001CN1313280A Benzheterocyclic derivatives
09/18/2001US6291452 Cholecystokinin antagonists.
09/13/2001WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists
09/13/2001WO2001066062A2 Process for preparing pure crystalline lorazepam
09/13/2001US20010021388 Cyclization of a triether with a diamine compound
09/13/2001CA2401928A1 Process for preparing pure crystalline lorazepam
09/12/2001EP1131039A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
09/07/2001WO2001055111A8 Biaryl compounds, their preparation and their use in therapy
09/06/2001US20010020093 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermeidate
09/06/2001US20010020019 Novel halo-alkoxycarbonyl prodrugs
09/05/2001EP0832061B1 Benzamide derivatives and their use as vasopressin antagonists
09/05/2001CN1311779A Succinoylamino lactams as inhibitors and as A beta protein production
09/04/2001US6284767 Retroviral protease inhibiting compounds
08/2001
08/30/2001WO2001015656A3 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents
08/29/2001CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions
08/28/2001US6281353 Method of making diazepine derivatives
08/23/2001WO2001060826A2 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
08/23/2001US20010016583 Therapeutic application of pro-apoptotic benzodiazepines
08/23/2001CA2395862A1 Succinoylamino carbocycles and heterocycles as inhibitors of a.beta. protein production
08/22/2001EP1124556A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof
08/22/2001CN1309122A Process for synthesizing 2-alkoxycarbonylmethyl-1,4-benzodiazepine
08/16/2001WO2000066106A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
08/16/2001US20010014738 Process for the preparation of imidazodiazepine intermediates
08/16/2001EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
08/16/2001EP1123928A1 1,5-benzodiazepine compounds, process for producing the same, and medicine
08/15/2001CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them
08/14/2001CA2162838C Process for preparing an alkylimidazolidone (meth)acrylate
08/09/2001WO2001056563A1 Adamantyl derivatives as anti-cancer agents
08/08/2001CN1307567A 1,5 benzodiazepine derivatives
08/02/2001WO2001055121A1 Azepine derivatives
08/02/2001WO2001055111A1 Biaryl compounds, their preparation and their use in therapy
08/02/2001US20010011087 Vitronectin receptor antagonists, their preparation and their use
07/2001
07/31/2001US6267973 Ectoin and ectoin derivatives as moisturizers in cosmetics
07/26/2001WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
07/26/2001WO2001053255A1 Gamma-secretase inhibitors
07/26/2001CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
07/26/2001CA2397543A1 Gamma-secretase inhibitors
07/18/2001EP1115758A2 Polymerization of olefins
07/12/2001WO2001049681A1 A method for the preparation of substituted benzene derivatives
07/12/2001WO2001002358A3 Cyclized amide derivatives for treating or preventing neuronal damage
07/10/2001US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases
07/10/2001CA2226691C Combinatorial 1,4-benzodiazepin-2,5-dione library
07/05/2001WO2001047899A1 Substituted piperazine derivatives as mtp inhibitors
07/05/2001WO2001047510A2 Methods and compositions related to modulators of annexin and cartilage homeostasis
07/05/2001DE19963235A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments
07/05/2001CA2394644A1 Substituted piperazine derivatives,the preparation thereof and their useas medicaments
07/04/2001EP1112250A1 Therapeutic compounds and methods
07/03/2001US6255481 Treating aqueous suspension of anhydrous nevirapine with hydrochloric acid then treating with sodium hydroxide yields the free base as a precipitate/hemihydrate which is then filtered from solution and water washed
06/2001
06/27/2001CN1301257A Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes
06/27/2001CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists
06/26/2001US6252067 Reacting 2,2,2-trifluoromethane sulfonate with corresponding amide compound in presence of potassium carbonate; refluxing
06/26/2001US6251949 Oxime derivatives, hydrazone derivatives and use thereof
06/21/2001WO2001044190A1 Anthracene derivatives as anti-cancer agents
06/21/2001CA2395170A1 Anti-cancer agents (iii)
06/14/2001WO2001042243A2 Protein kinase inhibitors
06/14/2001WO2001002373A8 Dihydrobenzodiazepins and their use for treating dyslipidemia
06/13/2001EP1105392A1 Process for the preparation of imidazodiazepine intermediates
06/13/2001EP1105359A1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
06/12/2001US6245767 Cardiovascualr disorders
06/07/2001WO2001040197A1 Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same
06/06/2001EP1104754A1 Novel sulfonyl derivatives
05/2001
05/30/2001EP1102752A1 Succinoylamino lactams as inhibitors of a beta protein production
05/30/2001EP1102743A1 Amide derivatives which are useful as cytokine inhibitors
05/29/2001US6239131 1,5 Benzodiazepine derivatives
05/25/2001WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/23/2001EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders
05/22/2001US6235778 Anticoagulants
05/16/2001EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
05/16/2001EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/15/2001CA2238978C Retroviral protease inhibiting compounds
05/10/2001WO2001004122A3 New 2,3-benzodiazepine derivatives
05/09/2001EP0855397B1 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same
05/03/2001WO2001030769A2 Process for alkylation of benzodiazepindione compounds
05/02/2001EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/02/2001CN1293666A Benzenesulfonamide-derivatives and their use as medicaments
05/02/2001CN1293663A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamix acids as matrix metal-protease
05/01/2001US6225465 Process for the aminocarbonylation of benzazepines and benzodiazepines
05/01/2001CA2037299C Gamma emitting, cck-a antagonists for pancreatic imaging
04/2001
04/26/2001WO2001029012A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
04/26/2001WO2001029011A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
04/26/2001WO2001029005A1 Bicyclic vasopressin agonists
04/26/2001CA2387886A1 Bicyclic vasopressin agonists
04/25/2001EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
04/25/2001CN1064960C Method for preparation of nitrazepam
04/24/2001US6222032 Conducting the c-alkylation or n-alkylation reaction in the presence of a slightly nucleophilic strong base comprising a phosphorus compound
04/19/2001WO2001027108A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
04/19/2001WO2001027102A1 Substituted diazepanes
04/19/2001WO2001027091A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
04/19/2001CA2387493A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production
04/19/2001CA2384544A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production
04/18/2001EP1091944A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 60